Ralph Meuwissen
- Cancer Research top 2%
- Oncology top 2%
- Cancer Cells and Metastasis 5
- Cancer-related Molecular Pathways 5
- Lung Cancer Research Studies 4
- Molecular Biology top 2%
- DNA Repair Mechanisms 4
- Epigenetics and DNA Methylation 3
- Biotechnology top 2%
- Cancer Research and Treatments 6
- Cell Biology top 5%
-
- Virus-based gene therapy research 3
-
- Neuroendocrine Tumor Research Advances 3
- Co-authors
- Anton BernsKemal Uğur TüfekçiŞermin GençMartin van der ValkJos JonkersJohn ZevenhovenHanneke van der GuldenHans Peterse
- Partner nations
- NetherlandsUnited StatesTürkiye
In The Last Decade
Ralph Meuwissen
25 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 1.0k
- Oncology 1.4k
- Molecular Biology 2.6k
- Biotechnology 245
- Cell Biology 302
Countries citing papers authored by Ralph Meuwissen
This map shows the geographic impact of Ralph Meuwissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Meuwissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Meuwissen more than expected).
Fields of papers citing papers by Ralph Meuwissen
This network shows the impact of papers produced by Ralph Meuwissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Meuwissen. The network helps show where Ralph Meuwissen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ralph Meuwissen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2015 | 9 | |
| 4 | 2013 | 456 | |
| 5 | 2013 | 158 | |
| 6 | 2012 | 161 | |
| 7 | 2011 | 258 | |
| 8 | 2010 | 37 | |
| 9 | Evaluation of the differences between International Standards on Auditing (ISA) and the standards of the US Public Company Accounting Oversight Board (PCAOB) | 2009 | 1 |
| 10 | 2005 | 31 | |
| 11 | 2005 | 218 | |
| 12 | 2004 | 473 | |
| 13 | 2004 | 11 | |
| 14 | 2003 | 430 | |
| 15 | Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancerbreakdown → | 2001 | 794 |
| 16 | 2001 | 148 | |
| 17 | 2001 | 25 | |
| 18 | 1999 | 36 | |
| 19 | 1997 | 39 | |
| 20 | 1996 | 106 |
About Ralph Meuwissen
Ralph Meuwissen is a scholar working on Biotechnology, Aging and Oncology, having authored 25 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer Research and Treatments (6 papers), Cancer Cells and Metastasis (5 papers), Cancer-related Molecular Pathways (5 papers), DNA Repair Mechanisms (4 papers), Lung Cancer Research Studies (4 papers), Virus-based gene therapy research (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.4k citations) and Molecular Biology (2.6k citations). Ralph Meuwissen has collaborated with scholars based in Netherlands, United States and Türkiye. Frequent co-authors include Anton Berns, Kemal Uğur Tüfekçi, Şermin Genç, Martin van der Valk, Jos Jonkers, John Zevenhoven, Anton Berns, Hanneke van der Gulden, Hans Peterse and Meryem Gülfem Öner. Their work appears in journals such as Nature, Nature Genetics and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.